Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Cidara Therapeutics (CDTX) stocks
Learn how to easily invest in Cidara Therapeutics stocks.
Cidara Therapeutics is a biotechnology business based in the US. Cidara Therapeutics stocks (CDTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.83 – a decrease of 3.73% over the previous week. Cidara Therapeutics employs 73 staff and has a trailing 12-month revenue of around $83.2 million.
How to buy Cidara Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CDTX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Cidara Therapeutics?
- Has coronavirus impacted Cidara Therapeutics shares?
- Cidara Therapeutics shares summary
- Compare share dealing platforms
- Is Cidara Therapeutics stock a buy or sell?
- Cidara Therapeutics performance over time
- Cidara Therapeutics's financials
- How volatile are Cidara Therapeutics shares?
- Does Cidara Therapeutics pay a dividend?
- Other common questions
Cidara Therapeutics stock price (NASDAQ:CDTX)Use our graph to track the performance of CDTX stocks over time.
Cidara Therapeutics shares at a glance
|Latest market close||$1.29|
|52-week range||$0.40 - $2.10|
|50-day moving average||$1.23|
|200-day moving average||$0.98|
|Wall St. target price||$6.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.12|
Buy Cidara Therapeutics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Cidara Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Cidara Therapeutics price performance over time
Historical closes compared with the close of $1.29 from 2023-05-30
|1 week (2023-05-25)||0.78%|
|1 month (2023-05-01)||22.86%|
|3 months (2023-03-01)||-34.18%|
|6 months (2022-12-01)||98.37%|
|1 year (2022-05-31)||180.43%|
|2 years (2021-05-28)||N/A|
|3 years (2020-06-01)||3.69|
|5 years (2018-06-01)||5.7|
Cidara Therapeutics financials
|Revenue TTM||$83.2 million|
|Gross profit TTM||$-11,232,000|
|Return on assets TTM||-7.74%|
|Return on equity TTM||-52.27%|
|Market capitalisation||$122.4 million|
TTM: trailing 12 months
Cidara Therapeutics share dividends
We're not expecting Cidara Therapeutics to pay a dividend over the next 12 months.
Cidara Therapeutics share price volatility
Over the last 12 months, Cidara Therapeutics's shares have ranged in value from as little as $0.4 up to $2.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cidara Therapeutics's is 1.329. This would suggest that Cidara Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cidara Therapeutics overview
Cidara Therapeutics, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014.
Stocks similar to Cidara Therapeutics
Cidara Therapeutics in the news
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
Cidara Therapeutics Presents New Preclinical Data on Novel Drug-Fc Conjugate CD388 at the 7th International Society for Influenza and Other Respiratory Virus Diseases Conference
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
Bad credit loans in Edmonton, Alberta
From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
How to buy Pepe (PEPE) in Canada
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
How to buy Arbitrum (ARB) in Canada
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
How to buy SSV Network (SSV) in Canada
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
How to buy USDD (USDD) in Canada
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
How to buy Blur (BLUR) in Canada
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
How to buy FLOKI Inu (FLOKI) in Canada
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
How to buy Aptos (APT) in Canada
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
How to buy EthereumPoW (ETHW) in Canada
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).